- Probiotics as Complementary Treatment for Metabolic Disorders
-
Le Barz M, Anhe FF, Varin TV, Desjardins Y, Levy E, Roy D, Urdaci MC, Marette A
- KMID: 2174024
- Diabetes Metab J.
- 2015 Aug;39(4):291-303.
- doi: 10.4093/dmj.2015.39.4.291
Over the past decade, growing evidence has established the gut microbiota as one of the most important determinants of metabolic disorders such as obesity and type 2 diabetes. Indeed, obesogenic... -
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: Figure Correction: Probiotics as Complementary Treatment for Metabolic Disorders
-
Le Barz M, Anhe FF, Varin TV, Desjardins Y, Levy E, Roy D, Urdaci MC, Marette A
- KMID: 2174021
- Diabetes Metab J.
- 2015 Oct;39(5):448-449.
- doi: 10.4093/dmj.2015.39.5.448
There was a spelling error in the Fig 2. -
- CITED
-
- Close
- SHARE
-
- Close
- Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases
-
Anhê FF, Jensen BAH, Perazza LR, Tchernof A, Schertzer JD, Marette A
- KMID: 2516877
- J Lipid Atheroscler.
- 2021 May;10(2):129-129.
- doi: 10.12997/jla.2021.10.2.123
Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects... -
- CITED
-
- Close
- SHARE
-
- Close
